APO Research
Talk to an analyst

APO RESEARCH · REPORT

Fexofenadine Hydrochloride Tablets

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Fexofenadine Hydrochloride Tablets Market Analysis and Forecast 2026-2032

27 December 2025191 pages

Choose your research edition.

Industry ResearchFexofenadine Hydrochloride Tablets Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Fexofenadine Hydrochloride Tablets Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Fexofenadine Hydrochloride Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Fexofenadine Hydrochloride Tablets Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Fexofenadine Hydrochloride Tablets Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Fexofenadine Hydrochloride Tablets market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Fexofenadine Hydrochloride Tablets is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Fexofenadine Hydrochloride Tablets is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Fexofenadine Hydrochloride Tablets is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Fexofenadine Hydrochloride Tablets is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Fexofenadine Hydrochloride Tablets include OPELLA HEALTHCARE FRANCE SAS, Sandoz, Sanofi, Lunan Pharmaceutical Group, Viatris, Teva Pharmaceuticals, Sun Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries and Dr. Reddy's Laboratories, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Fexofenadine Hydrochloride Tablets, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Fexofenadine Hydrochloride Tablets, also provides the sales of main regions and countries. Of the upcoming market potential for Fexofenadine Hydrochloride Tablets, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Fexofenadine Hydrochloride Tablets sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Fexofenadine Hydrochloride Tablets market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Fexofenadine Hydrochloride Tablets sales, projected growth trends, production technology, application and end-user industry.

Fexofenadine Hydrochloride Tablets Segment by Company

OPELLA HEALTHCARE FRANCE SAS

Sandoz

Sanofi

Lunan Pharmaceutical Group

Viatris

Teva Pharmaceuticals

Sun Pharmaceutical Industries Ltd.

Sun Pharmaceutical Industries

Dr. Reddy's Laboratories

CSPC Pharmaceutical Group

Fexofenadine Hydrochloride Tablets Segment by Type

120mg

180mg

60mg

Fexofenadine Hydrochloride Tablets Segment by Application

Clinic

Hospital

Others

Fexofenadine Hydrochloride Tablets Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Fexofenadine Hydrochloride Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Fexofenadine Hydrochloride Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Fexofenadine Hydrochloride Tablets.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Fexofenadine Hydrochloride Tablets in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Fexofenadine Hydrochloride Tablets manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Fexofenadine Hydrochloride Tablets sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Fexofenadine Hydrochloride Tablets Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. 120mg Major Manufacturers Table 3. 180mg Major Manufacturers Table 4. 60mg Major Manufacturers Table 5. Global Fexofenadine Hydrochloride Tablets Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Clinic Major Manufacturers Table 7. Hospital Major Manufacturers Table 8. Others Major Manufacturers Table 9. Fexofenadine Hydrochloride Tablets Industry Trends Table 10. Fexofenadine Hydrochloride Tablets Industry Drivers Table 11. Fexofenadine Hydrochloride Tablets Industry Opportunities and Challenges Table 12. Fexofenadine Hydrochloride Tablets Industry Restraints Table 13. Global Fexofenadine Hydrochloride Tablets Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 14. Global Fexofenadine Hydrochloride Tablets Revenue by Region (2021-2026) & (US$ Million) Table 15. Global Fexofenadine Hydrochloride Tablets Revenue by Region (2027-2032) & (US$ Million) Table 16. Global Fexofenadine Hydrochloride Tablets Revenue Market Share by Region (2021-2026) Table 17. Global Fexofenadine Hydrochloride Tablets Revenue Market Share by Region (2027-2032) Table 18. Global Fexofenadine Hydrochloride Tablets Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (Tons) Table 19. Global Fexofenadine Hydrochloride Tablets Sales by Region (2021-2026) & (Tons) Table 20. Global Fexofenadine Hydrochloride Tablets Sales by Region (2027-2032) & (Tons) Table 21. Global Fexofenadine Hydrochloride Tablets Sales Market Share by Region (2021-2026) Table 22. Global Fexofenadine Hydrochloride Tablets Sales Market Share by Region (2027-2032) Table 23. Global Fexofenadine Hydrochloride Tablets Revenue by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Fexofenadine Hydrochloride Tablets Revenue Market Share by Manufacturers (2021-2026) Table 25. Global Fexofenadine Hydrochloride Tablets Sales by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Fexofenadine Hydrochloride Tablets Sales Market Share by Manufacturers (2021-2026) Table 27. Global Fexofenadine Hydrochloride Tablets Sales Price (US$/Ton) of Manufacturers (2021-2026) Table 28. Global Fexofenadine Hydrochloride Tablets Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 29. Global Fexofenadine Hydrochloride Tablets Key Manufacturers Manufacturing Sites & Headquarters Table 30. Global Fexofenadine Hydrochloride Tablets Manufacturers, Product Type & Application Table 31. Global Fexofenadine Hydrochloride Tablets Manufacturers' Establishment Date Table 32. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 33. Global Fexofenadine Hydrochloride Tablets by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 34. Global Fexofenadine Hydrochloride Tablets Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Fexofenadine Hydrochloride Tablets Revenue by Type (2021-2026) & (US$ Million) Table 36. Global Fexofenadine Hydrochloride Tablets Revenue by Type (2027-2032) & (US$ Million) Table 37. Global Fexofenadine Hydrochloride Tablets Revenue Market Share by Type (2021-2026) Table 38. Global Fexofenadine Hydrochloride Tablets Revenue Market Share by Type (2027-2032) Table 39. Global Fexofenadine Hydrochloride Tablets Sales by Type 2021 VS 2025 VS 2032 (Tons) Table 40. Global Fexofenadine Hydrochloride Tablets Sales by Type (2021-2026) & (Tons) Table 41. Global Fexofenadine Hydrochloride Tablets Sales by Type (2027-2032) & (Tons) Table 42. Global Fexofenadine Hydrochloride Tablets Sales Market Share by Type (2021-2026) Table 43. Global Fexofenadine Hydrochloride Tablets Sales Market Share by Type (2027-2032) Table 44. Global Fexofenadine Hydrochloride Tablets Price by Type (2021-2026) & (US$/Ton) Table 45. Global Fexofenadine Hydrochloride Tablets Price by Type (2027-2032) & (US$/Ton) Table 46. Global Fexofenadine Hydrochloride Tablets Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Fexofenadine Hydrochloride Tablets Revenue by Application (2021-2026) & (US$ Million) Table 48. Global Fexofenadine Hydrochloride Tablets Revenue by Application (2027-2032) & (US$ Million) Table 49. Global Fexofenadine Hydrochloride Tablets Revenue Market Share by Application (2021-2026) Table 50. Global Fexofenadine Hydrochloride Tablets Revenue Market Share by Application (2027-2032) Table 51. Global Fexofenadine Hydrochloride Tablets Sales by Application 2021 VS 2025 VS 2032 (Tons) Table 52. Global Fexofenadine Hydrochloride Tablets Sales by Application (2021-2026) & (Tons) Table 53. Global Fexofenadine Hydrochloride Tablets Sales by Application (2027-2032) & (Tons) Table 54. Global Fexofenadine Hydrochloride Tablets Sales Market Share by Application (2021-2026) Table 55. Global Fexofenadine Hydrochloride Tablets Sales Market Share by Application (2027-2032) Table 56. Global Fexofenadine Hydrochloride Tablets Price by Application (2021-2026) & (US$/Ton) Table 57. Global Fexofenadine Hydrochloride Tablets Price by Application (2027-2032) & (US$/Ton) Table 58. OPELLA HEALTHCARE FRANCE SAS Company Information Table 59. OPELLA HEALTHCARE FRANCE SAS Business Overview Table 60. OPELLA HEALTHCARE FRANCE SAS Fexofenadine Hydrochloride Tablets Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 61. OPELLA HEALTHCARE FRANCE SAS Fexofenadine Hydrochloride Tablets Product Portfolio Table 62. OPELLA HEALTHCARE FRANCE SAS Recent Development Table 63. Sandoz Company Information Table 64. Sandoz Business Overview Table 65. Sandoz Fexofenadine Hydrochloride Tablets Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 66. Sandoz Fexofenadine Hydrochloride Tablets Product Portfolio Table 67. Sandoz Recent Development Table 68. Sanofi Company Information Table 69. Sanofi Business Overview Table 70. Sanofi Fexofenadine Hydrochloride Tablets Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 71. Sanofi Fexofenadine Hydrochloride Tablets Product Portfolio Table 72. Sanofi Recent Development Table 73. Lunan Pharmaceutical Group Company Information Table 74. Lunan Pharmaceutical Group Business Overview Table 75. Lunan Pharmaceutical Group Fexofenadine Hydrochloride Tablets Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 76. Lunan Pharmaceutical Group Fexofenadine Hydrochloride Tablets Product Portfolio Table 77. Lunan Pharmaceutical Group Recent Development Table 78. Viatris Company Information Table 79. Viatris Business Overview Table 80. Viatris Fexofenadine Hydrochloride Tablets Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 81. Viatris Fexofenadine Hydrochloride Tablets Product Portfolio Table 82. Viatris Recent Development Table 83. Teva Pharmaceuticals Company Information Table 84. Teva Pharmaceuticals Business Overview Table 85. Teva Pharmaceuticals Fexofenadine Hydrochloride Tablets Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 86. Teva Pharmaceuticals Fexofenadine Hydrochloride Tablets Product Portfolio Table 87. Teva Pharmaceuticals Recent Development Table 88. Sun Pharmaceutical Industries Ltd. Company Information Table 89. Sun Pharmaceutical Industries Ltd. Business Overview Table 90. Sun Pharmaceutical Industries Ltd. Fexofenadine Hydrochloride Tablets Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 91. Sun Pharmaceutical Industries Ltd. Fexofenadine Hydrochloride Tablets Product Portfolio Table 92. Sun Pharmaceutical Industries Ltd. Recent Development Table 93. Sun Pharmaceutical Industries Company Information Table 94. Sun Pharmaceutical Industries Business Overview Table 95. Sun Pharmaceutical Industries Fexofenadine Hydrochloride Tablets Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 96. Sun Pharmaceutical Industries Fexofenadine Hydrochloride Tablets Product Portfolio Table 97. Sun Pharmaceutical Industries Recent Development Table 98. Dr. Reddy's Laboratories Company Information Table 99. Dr. Reddy's Laboratories Business Overview Table 100. Dr. Reddy's Laboratories Fexofenadine Hydrochloride Tablets Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 101. Dr. Reddy's Laboratories Fexofenadine Hydrochloride Tablets Product Portfolio Table 102. Dr. Reddy's Laboratories Recent Development Table 103. CSPC Pharmaceutical Group Company Information Table 104. CSPC Pharmaceutical Group Business Overview Table 105. CSPC Pharmaceutical Group Fexofenadine Hydrochloride Tablets Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 106. CSPC Pharmaceutical Group Fexofenadine Hydrochloride Tablets Product Portfolio Table 107. CSPC Pharmaceutical Group Recent Development Table 108. North America Fexofenadine Hydrochloride Tablets Revenue by Type (2021-2026) & (US$ Million) Table 109. North America Fexofenadine Hydrochloride Tablets Revenue by Type (2027-2032) & (US$ Million) Table 110. North America Fexofenadine Hydrochloride Tablets Sales by Type (2021-2026) & (Tons) Table 111. North America Fexofenadine Hydrochloride Tablets Sales by Type (2027-2032) & (Tons) Table 112. North America Fexofenadine Hydrochloride Tablets Sales Price by Type (2021-2026) & (US$/Ton) Table 113. North America Fexofenadine Hydrochloride Tablets Sales Price by Type (2027-2032) & (US$/Ton) Table 114. North America Fexofenadine Hydrochloride Tablets Revenue by Application (2021-2026) & (US$ Million) Table 115. North America Fexofenadine Hydrochloride Tablets Revenue by Application (2027-2032) & (US$ Million) Table 116. North America Fexofenadine Hydrochloride Tablets Sales by Application (2021-2026) & (Tons) Table 117. North America Fexofenadine Hydrochloride Tablets Sales by Application (2027-2032) & (Tons) Table 118. North America Fexofenadine Hydrochloride Tablets Sales Price by Application (2021-2026) & (US$/Ton) Table 119. North America Fexofenadine Hydrochloride Tablets Sales Price by Application (2027-2032) & (US$/Ton) Table 120. North America Fexofenadine Hydrochloride Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 121. North America Fexofenadine Hydrochloride Tablets Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 122. North America Fexofenadine Hydrochloride Tablets Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 123. North America Fexofenadine Hydrochloride Tablets Sales by Country (2021 VS 2025 VS 2032) & (Tons) Table 124. North America Fexofenadine Hydrochloride Tablets Sales by Country (2021-2026) & (Tons) Table 125. North America Fexofenadine Hydrochloride Tablets Sales by Country (2027-2032) & (Tons) Table 126. North America Fexofenadine Hydrochloride Tablets Sales Price by Country (2021-2026) & (US$/Ton) Table 127. North America Fexofenadine Hydrochloride Tablets Sales Price by Country (2027-2032) & (US$/Ton) Table 128. United States Fexofenadine Hydrochloride Tablets Revenue (2021-2032) & (US$ Million) Table 129. Canada Fexofenadine Hydrochloride Tablets Revenue (2021-2032) & (US$ Million) Table 130. Mexico Fexofenadine Hydrochloride Tablets Revenue (2021-2032) & (US$ Million) Table 131. Europe Fexofenadine Hydrochloride Tablets Revenue by Type (2021-2026) & (US$ Million) Table 132. Europe Fexofenadine Hydrochloride Tablets Revenue by Type (2027-2032) & (US$ Million) Table 133. Europe Fexofenadine Hydrochloride Tablets Sales by Type (2021-2026) & (Tons) Table 134. Europe Fexofenadine Hydrochloride Tablets Sales by Type (2027-2032) & (Tons) Table 135. Europe Fexofenadine Hydrochloride Tablets Sales Price by Type (2021-2026) & (US$/Ton) Table 136. Europe Fexofenadine Hydrochloride Tablets Sales Price by Type (2027-2032) & (US$/Ton) Table 137. Europe Fexofenadine Hydrochloride Tablets Revenue by Application (2021-2026) & (US$ Million) Table 138. Europe Fexofenadine Hydrochloride Tablets Revenue by Application (2027-2032) & (US$ Million) Table 139. Europe Fexofenadine Hydrochloride Tablets Sales by Application (2021-2026) & (Tons) Table 140. Europe Fexofenadine Hydrochloride Tablets Sales by Application (2027-2032) & (Tons) Table 141. Europe Fexofenadine Hydrochloride Tablets Sales Price by Application (2021-2026) & (US$/Ton) Table 142. Europe Fexofenadine Hydrochloride Tablets Sales Price by Application (2027-2032) & (US$/Ton) Table 143. Europe Fexofenadine Hydrochloride Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 144. Europe Fexofenadine Hydrochloride Tablets Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 145. Europe Fexofenadine Hydrochloride Tablets Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 146. Europe Fexofenadine Hydrochloride Tablets Sales by Country (2021 VS 2025 VS 2032) & (Tons) Table 147. Europe Fexofenadine Hydrochloride Tablets Sales by Country (2021-2026) & (Tons) Table 148. Europe Fexofenadine Hydrochloride Tablets Sales by Country (2027-2032) & (Tons) Table 149. Europe Fexofenadine Hydrochloride Tablets Sales Price by Country (2021-2026) & (US$/Ton) Table 150. Europe Fexofenadine Hydrochloride Tablets Sales Price by Country (2027-2032) & (US$/Ton) Table 151. Germany Fexofenadine Hydrochloride Tablets Revenue (2021-2032) & (US$ Million) Table 152. France Fexofenadine Hydrochloride Tablets Revenue (2021-2032) & (US$ Million) Table 153. U.K. Fexofenadine Hydrochloride Tablets Revenue (2021-2032) & (US$ Million) Table 154. Italy Fexofenadine Hydrochloride Tablets Revenue (2021-2032) & (US$ Million) Table 155. Russia Fexofenadine Hydrochloride Tablets Revenue (2021-2032) & (US$ Million) Table 156. Spain Fexofenadine Hydrochloride Tablets Revenue (2021-2032) & (US$ Million) Table 157. Netherlands Fexofenadine Hydrochloride Tablets Revenue (2021-2032) & (US$ Million) Table 158. Switzerland Fexofenadine Hydrochloride Tablets Revenue (2021-2032) & (US$ Million) Table 159. Sweden Fexofenadine Hydrochloride Tablets Revenue (2021-2032) & (US$ Million) Table 160. Poland Fexofenadine Hydrochloride Tablets Revenue (2021-2032) & (US$ Million) Table 161. China Fexofenadine Hydrochloride Tablets Revenue by Type (2021-2026) & (US$ Million) Table 162. China Fexofenadine Hydrochloride Tablets Revenue by Type (2027-2032) & (US$ Million) Table 163. China Fexofenadine Hydrochloride Tablets Sales by Type (2021-2026) & (Tons) Table 164. China Fexofenadine Hydrochloride Tablets Sales by Type (2027-2032) & (Tons) Table 165. China Fexofenadine Hydrochloride Tablets Sales Price by Type (2021-2026) & (US$/Ton) Table 166. China Fexofenadine Hydrochloride Tablets Sales Price by Type (2027-2032) & (US$/Ton) Table 167. China Fexofenadine Hydrochloride Tablets Revenue by Application (2021-2026) & (US$ Million) Table 168. China Fexofenadine Hydrochloride Tablets Revenue by Application (2027-2032) & (US$ Million) Table 169. China Fexofenadine Hydrochloride Tablets Sales by Application (2021-2026) & (Tons) Table 170. China Fexofenadine Hydrochloride Tablets Sales by Application (2027-2032) & (Tons) Table 171. China Fexofenadine Hydrochloride Tablets Sales Price by Application (2021-2026) & (US$/Ton) Table 172. China Fexofenadine Hydrochloride Tablets Sales Price by Application (2027-2032) & (US$/Ton) Table 173. Asia Fexofenadine Hydrochloride Tablets Revenue by Type (2021-2026) & (US$ Million) Table 174. Asia Fexofenadine Hydrochloride Tablets Revenue by Type (2027-2032) & (US$ Million) Table 175. Asia Fexofenadine Hydrochloride Tablets Sales by Type (2021-2026) & (Tons) Table 176. Asia Fexofenadine Hydrochloride Tablets Sales by Type (2027-2032) & (Tons) Table 177. Asia Fexofenadine Hydrochloride Tablets Sales Price by Type (2021-2026) & (US$/Ton) Table 178. Asia Fexofenadine Hydrochloride Tablets Sales Price by Type (2027-2032) & (US$/Ton) Table 179. Asia Fexofenadine Hydrochloride Tablets Revenue by Application (2021-2026) & (US$ Million) Table 180. Asia Fexofenadine Hydrochloride Tablets Revenue by Application (2027-2032) & (US$ Million) Table 181. Asia Fexofenadine Hydrochloride Tablets Sales by Application (2021-2026) & (Tons) Table 182. Asia Fexofenadine Hydrochloride Tablets Sales by Application (2027-2032) & (Tons) Table 183. Asia Fexofenadine Hydrochloride Tablets Sales Price by Application (2021-2026) & (US$/Ton) Table 184. Asia Fexofenadine Hydrochloride Tablets Sales Price by Application (2027-2032) & (US$/Ton) Table 185. Asia Fexofenadine Hydrochloride Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 186. Asia Fexofenadine Hydrochloride Tablets Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 187. Asia Fexofenadine Hydrochloride Tablets Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 188. Asia Fexofenadine Hydrochloride Tablets Sales by Country (2021 VS 2025 VS 2032) & (Tons) Table 189. Asia Fexofenadine Hydrochloride Tablets Sales by Country (2021-2026) & (Tons) Table 190. Asia Fexofenadine Hydrochloride Tablets Sales by Country (2027-2032) & (Tons) Table 191. Asia Fexofenadine Hydrochloride Tablets Sales Price by Country (2021-2026) & (US$/Ton) Table 192. Asia Fexofenadine Hydrochloride Tablets Sales Price by Country (2027-2032) & (US$/Ton) Table 193. Japan Fexofenadine Hydrochloride Tablets Revenue (2021-2032) & (US$ Million) Table 194. South Korea Fexofenadine Hydrochloride Tablets Revenue (2021-2032) & (US$ Million) Table 195. India Fexofenadine Hydrochloride Tablets Revenue (2021-2032) & (US$ Million) Table 196. Australia Fexofenadine Hydrochloride Tablets Revenue (2021-2032) & (US$ Million) Table 197. Taiwan Fexofenadine Hydrochloride Tablets Revenue (2021-2032) & (US$ Million) Table 198. Southeast Asia Fexofenadine Hydrochloride Tablets Revenue (2021-2032) & (US$ Million) Table 199. SAMEA Fexofenadine Hydrochloride Tablets Revenue by Type (2021-2026) & (US$ Million) Table 200. SAMEA Fexofenadine Hydrochloride Tablets Revenue by Type (2027-2032) & (US$ Million) Table 201. SAMEA Fexofenadine Hydrochloride Tablets Sales by Type (2021-2026) & (Tons) Table 202. SAMEA Fexofenadine Hydrochloride Tablets Sales by Type (2027-2032) & (Tons) Table 203. SAMEA Fexofenadine Hydrochloride Tablets Sales Price by Type (2021-2026) & (US$/Ton) Table 204. SAMEA Fexofenadine Hydrochloride Tablets Sales Price by Type (2027-2032) & (US$/Ton) Table 205. SAMEA Fexofenadine Hydrochloride Tablets Revenue by Application (2021-2026) & (US$ Million) Table 206. SAMEA Fexofenadine Hydrochloride Tablets Revenue by Application (2027-2032) & (US$ Million) Table 207. SAMEA Fexofenadine Hydrochloride Tablets Sales by Application (2021-2026) & (Tons) Table 208. SAMEA Fexofenadine Hydrochloride Tablets Sales by Application (2027-2032) & (Tons) Table 209. SAMEA Fexofenadine Hydrochloride Tablets Sales Price by Application (2021-2026) & (US$/Ton) Table 210. SAMEA Fexofenadine Hydrochloride Tablets Sales Price by Application (2027-2032) & (US$/Ton) Table 211. SAMEA Fexofenadine Hydrochloride Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 212. SAMEA Fexofenadine Hydrochloride Tablets Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 213. SAMEA Fexofenadine Hydrochloride Tablets Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 214. SAMEA Fexofenadine Hydrochloride Tablets Sales by Country (2021 VS 2025 VS 2032) & (Tons) Table 215. SAMEA Fexofenadine Hydrochloride Tablets Sales by Country (2021-2026) & (Tons) Table 216. SAMEA Fexofenadine Hydrochloride Tablets Sales by Country (2027-2032) & (Tons) Table 217. SAMEA Fexofenadine Hydrochloride Tablets Sales Price by Country (2021-2026) & (US$/Ton) Table 218. SAMEA Fexofenadine Hydrochloride Tablets Sales Price by Country (2027-2032) & (US$/Ton) Table 219. Brazil Fexofenadine Hydrochloride Tablets Revenue (2021-2032) & (US$ Million) Table 220. Argentina Fexofenadine Hydrochloride Tablets Revenue (2021-2032) & (US$ Million) Table 221. Chile Fexofenadine Hydrochloride Tablets Revenue (2021-2032) & (US$ Million) Table 222. Colombia Fexofenadine Hydrochloride Tablets Revenue (2021-2032) & (US$ Million) Table 223. Peru Fexofenadine Hydrochloride Tablets Revenue (2021-2032) & (US$ Million) Table 224. Saudi Arabia Fexofenadine Hydrochloride Tablets Revenue (2021-2032) & (US$ Million) Table 225. Israel Fexofenadine Hydrochloride Tablets Revenue (2021-2032) & (US$ Million) Table 226. UAE Fexofenadine Hydrochloride Tablets Revenue (2021-2032) & (US$ Million) Table 227. Turkey Fexofenadine Hydrochloride Tablets Revenue (2021-2032) & (US$ Million) Table 228. Iran Fexofenadine Hydrochloride Tablets Revenue (2021-2032) & (US$ Million) Table 229. Egypt Fexofenadine Hydrochloride Tablets Revenue (2021-2032) & (US$ Million) Table 230. Key Raw Materials Table 231. Raw Materials Key Suppliers Table 232. Fexofenadine Hydrochloride Tablets Distributors List Table 233. Fexofenadine Hydrochloride Tablets Customers List Table 234. Research Programs/Design for This Report Table 235. Authors List of This Report Table 236. Secondary Sources Table 237. Primary Sources List of Figures Figure 1. Fexofenadine Hydrochloride Tablets Image Figure 2. Global Fexofenadine Hydrochloride Tablets Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Fexofenadine Hydrochloride Tablets Market Size Share 2021 VS 2025 VS 2032 Figure 4. 120mg Image Figure 5. 180mg Image Figure 6. 60mg Image Figure 7. Global Fexofenadine Hydrochloride Tablets Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Fexofenadine Hydrochloride Tablets Market Size Share 2021 VS 2025 VS 2032 Figure 9. Clinic Image Figure 10. Hospital Image Figure 11. Others Image Figure 12. Global Fexofenadine Hydrochloride Tablets Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Fexofenadine Hydrochloride Tablets Revenue (2021-2032) & (US$ Million) Figure 14. Global Fexofenadine Hydrochloride Tablets Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 15. Global Fexofenadine Hydrochloride Tablets Revenue Market Share by Region: 2025 Versus 2032 Figure 16. Global Fexofenadine Hydrochloride Tablets Revenue Market Share by Region (2021-2032) Figure 17. Global Fexofenadine Hydrochloride Tablets Sales (2021-2032) & (Tons) Figure 18. Global Fexofenadine Hydrochloride Tablets Sales by Region: 2021 VS 2025 VS 2032 (Tons) Figure 19. Global Fexofenadine Hydrochloride Tablets Sales Market Share by Region (2021-2032) Figure 20. US & Canada & Mexico Fexofenadine Hydrochloride Tablets Sales YoY (2021-2032) & (Tons) Figure 21. Europe Fexofenadine Hydrochloride Tablets Sales YoY (2021-2032) & (Tons) Figure 22. China Fexofenadine Hydrochloride Tablets Sales YoY (2021-2032) & (Tons) Figure 23. Asia (Excluding China) Fexofenadine Hydrochloride Tablets Sales YoY (2021-2032) & (Tons) Figure 24. South America, Middle East and Africa Fexofenadine Hydrochloride Tablets Sales YoY (2021-2032) & (Tons) Figure 25. Global Fexofenadine Hydrochloride Tablets Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 26. Global Fexofenadine Hydrochloride Tablets Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 27. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 28. Global Fexofenadine Hydrochloride Tablets Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Fexofenadine Hydrochloride Tablets Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 30. Global Fexofenadine Hydrochloride Tablets Revenue Market Share by Type (2021-2032) Figure 31. Global Fexofenadine Hydrochloride Tablets Sales by Type (2021 VS 2025 VS 2032) & (Tons) Figure 32. Global Fexofenadine Hydrochloride Tablets Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Fexofenadine Hydrochloride Tablets Sales Market Share by Type (2021-2032) Figure 34. Global Fexofenadine Hydrochloride Tablets Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 35. Global Fexofenadine Hydrochloride Tablets Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 36. Global Fexofenadine Hydrochloride Tablets Revenue Market Share by Application (2021-2032) Figure 37. Global Fexofenadine Hydrochloride Tablets Sales by Application (2021 VS 2025 VS 2032) & (Tons) Figure 38. Global Fexofenadine Hydrochloride Tablets Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Fexofenadine Hydrochloride Tablets Sales Market Share by Application (2021-2032) Figure 40. North America Fexofenadine Hydrochloride Tablets Revenue Share by Type (2021-2032) Figure 41. North America Fexofenadine Hydrochloride Tablets Sales Share by Type (2021-2032) Figure 42. North America Fexofenadine Hydrochloride Tablets Revenue Share by Application (2021-2032) Figure 43. North America Fexofenadine Hydrochloride Tablets Sales Share by Application (2021-2032) Figure 44. North America Fexofenadine Hydrochloride Tablets Revenue Share by Country (2021-2032) Figure 45. North America Fexofenadine Hydrochloride Tablets Sales Share by Country (2021-2032) Figure 46. Europe Fexofenadine Hydrochloride Tablets Revenue Share by Type (2021-2032) Figure 47. Europe Fexofenadine Hydrochloride Tablets Sales Share by Type (2021-2032) Figure 48. Europe Fexofenadine Hydrochloride Tablets Revenue Share by Application (2021-2032) Figure 49. Europe Fexofenadine Hydrochloride Tablets Sales Share by Application (2021-2032) Figure 50. Europe Fexofenadine Hydrochloride Tablets Revenue Share by Country (2021-2032) Figure 51. Europe Fexofenadine Hydrochloride Tablets Sales Share by Country (2021-2032) Figure 52. China Fexofenadine Hydrochloride Tablets Revenue Share by Type (2021-2032) Figure 53. China Fexofenadine Hydrochloride Tablets Sales Share by Type (2021-2032) Figure 54. China Fexofenadine Hydrochloride Tablets Revenue Share by Application (2021-2032) Figure 55. China Fexofenadine Hydrochloride Tablets Sales Share by Application (2021-2032) Figure 56. Asia Fexofenadine Hydrochloride Tablets Revenue Share by Type (2021-2032) Figure 57. Asia Fexofenadine Hydrochloride Tablets Sales Share by Type (2021-2032) Figure 58. Asia Fexofenadine Hydrochloride Tablets Revenue Share by Application (2021-2032) Figure 59. Asia Fexofenadine Hydrochloride Tablets Sales Share by Application (2021-2032) Figure 60. Asia Fexofenadine Hydrochloride Tablets Revenue Share by Country (2021-2032) Figure 61. Asia Fexofenadine Hydrochloride Tablets Sales Share by Country (2021-2032) Figure 62. SAMEA Fexofenadine Hydrochloride Tablets Revenue Share by Type (2021-2032) Figure 63. SAMEA Fexofenadine Hydrochloride Tablets Sales Share by Type (2021-2032) Figure 64. SAMEA Fexofenadine Hydrochloride Tablets Revenue Share by Application (2021-2032) Figure 65. SAMEA Fexofenadine Hydrochloride Tablets Sales Share by Application (2021-2032) Figure 66. SAMEA Fexofenadine Hydrochloride Tablets Revenue Share by Country (2021-2032) Figure 67. SAMEA Fexofenadine Hydrochloride Tablets Sales Share by Country (2021-2032) Figure 68. Fexofenadine Hydrochloride Tablets Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Fexofenadine Hydrochloride Tablets Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • 120mg
  • 180mg
  • 60mg
Applications
  • Clinic
  • Hospital
  • Others
Companies covered
  • OPELLA HEALTHCARE FRANCE SAS
  • Sandoz
  • Sanofi
  • Lunan Pharmaceutical Group
  • Viatris
  • Teva Pharmaceuticals
  • Sun Pharmaceutical Industries Ltd.
  • Sun Pharmaceutical Industries
  • Dr. Reddy's Laboratories
  • CSPC Pharmaceutical Group

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Fexofenadine Hydrochloride Tablets Market by Type
  3. 1.2.1 Global Fexofenadine Hydrochloride Tablets Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 120mg
  5. 1.2.3 180mg
  6. 1.2.4 60mg
  7. 1.3 Fexofenadine Hydrochloride Tablets Market by Application
  8. 1.3.1 Global Fexofenadine Hydrochloride Tablets Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Clinic
  10. 1.3.3 Hospital
  11. 1.3.4 Others
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Fexofenadine Hydrochloride Tablets Market Dynamics
  1. 2.1 Fexofenadine Hydrochloride Tablets Industry Trends
  2. 2.2 Fexofenadine Hydrochloride Tablets Industry Drivers
  3. 2.3 Fexofenadine Hydrochloride Tablets Industry Opportunities and Challenges
  4. 2.4 Fexofenadine Hydrochloride Tablets Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Fexofenadine Hydrochloride Tablets Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Fexofenadine Hydrochloride Tablets Revenue by Region
  3. 3.2.1 Global Fexofenadine Hydrochloride Tablets Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Fexofenadine Hydrochloride Tablets Revenue by Region (2021-2026)
  5. 3.2.3 Global Fexofenadine Hydrochloride Tablets Revenue by Region (2027-2032)
  6. 3.2.4 Global Fexofenadine Hydrochloride Tablets Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Fexofenadine Hydrochloride Tablets Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Fexofenadine Hydrochloride Tablets Sales by Region
  9. 3.4.1 Global Fexofenadine Hydrochloride Tablets Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Fexofenadine Hydrochloride Tablets Sales by Region (2021-2026)
  11. 3.4.3 Global Fexofenadine Hydrochloride Tablets Sales by Region (2027-2032)
  12. 3.4.4 Global Fexofenadine Hydrochloride Tablets Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Fexofenadine Hydrochloride Tablets Revenue by Manufacturers
  2. 4.1.1 Global Fexofenadine Hydrochloride Tablets Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Fexofenadine Hydrochloride Tablets Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Fexofenadine Hydrochloride Tablets Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Fexofenadine Hydrochloride Tablets Sales by Manufacturers
  6. 4.2.1 Global Fexofenadine Hydrochloride Tablets Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Fexofenadine Hydrochloride Tablets Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Fexofenadine Hydrochloride Tablets Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Fexofenadine Hydrochloride Tablets Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Fexofenadine Hydrochloride Tablets Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Fexofenadine Hydrochloride Tablets Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Fexofenadine Hydrochloride Tablets Manufacturers, Product Type & Application
  13. 4.7 Global Fexofenadine Hydrochloride Tablets Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Fexofenadine Hydrochloride Tablets Market CR5 and HHI
  16. 4.8.2 2025 Fexofenadine Hydrochloride Tablets Tier 1, Tier 2, and Tier 3
5 Fexofenadine Hydrochloride Tablets Market by Type
  1. 5.1 Global Fexofenadine Hydrochloride Tablets Revenue by Type
  2. 5.1.1 Global Fexofenadine Hydrochloride Tablets Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Fexofenadine Hydrochloride Tablets Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Fexofenadine Hydrochloride Tablets Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Fexofenadine Hydrochloride Tablets Sales by Type
  6. 5.2.1 Global Fexofenadine Hydrochloride Tablets Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Fexofenadine Hydrochloride Tablets Sales by Type (2021-2032) & (Tons)
  8. 5.2.3 Global Fexofenadine Hydrochloride Tablets Sales Market Share by Type (2021-2032)
  9. 5.3 Global Fexofenadine Hydrochloride Tablets Price by Type
6 Fexofenadine Hydrochloride Tablets Market by Application
  1. 6.1 Global Fexofenadine Hydrochloride Tablets Revenue by Application
  2. 6.1.1 Global Fexofenadine Hydrochloride Tablets Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Fexofenadine Hydrochloride Tablets Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Fexofenadine Hydrochloride Tablets Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Fexofenadine Hydrochloride Tablets Sales by Application
  6. 6.2.1 Global Fexofenadine Hydrochloride Tablets Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Fexofenadine Hydrochloride Tablets Sales by Application (2021-2032) & (Tons)
  8. 6.2.3 Global Fexofenadine Hydrochloride Tablets Sales Market Share by Application (2021-2032)
  9. 6.3 Global Fexofenadine Hydrochloride Tablets Price by Application
7 Company Profiles
  1. 7.1 OPELLA HEALTHCARE FRANCE SAS
  2. 7.1.1 OPELLA HEALTHCARE FRANCE SAS Company Information
  3. 7.1.2 OPELLA HEALTHCARE FRANCE SAS Business Overview
  4. 7.1.3 OPELLA HEALTHCARE FRANCE SAS Fexofenadine Hydrochloride Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 OPELLA HEALTHCARE FRANCE SAS Fexofenadine Hydrochloride Tablets Product Portfolio
  6. 7.1.5 OPELLA HEALTHCARE FRANCE SAS Recent Developments
  7. 7.2 Sandoz
  8. 7.2.1 Sandoz Company Information
  9. 7.2.2 Sandoz Business Overview
  10. 7.2.3 Sandoz Fexofenadine Hydrochloride Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Sandoz Fexofenadine Hydrochloride Tablets Product Portfolio
  12. 7.2.5 Sandoz Recent Developments
  13. 7.3 Sanofi
  14. 7.3.1 Sanofi Company Information
  15. 7.3.2 Sanofi Business Overview
  16. 7.3.3 Sanofi Fexofenadine Hydrochloride Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Sanofi Fexofenadine Hydrochloride Tablets Product Portfolio
  18. 7.3.5 Sanofi Recent Developments
  19. 7.4 Lunan Pharmaceutical Group
  20. 7.4.1 Lunan Pharmaceutical Group Company Information
  21. 7.4.2 Lunan Pharmaceutical Group Business Overview
  22. 7.4.3 Lunan Pharmaceutical Group Fexofenadine Hydrochloride Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Lunan Pharmaceutical Group Fexofenadine Hydrochloride Tablets Product Portfolio
  24. 7.4.5 Lunan Pharmaceutical Group Recent Developments
  25. 7.5 Viatris
  26. 7.5.1 Viatris Company Information
  27. 7.5.2 Viatris Business Overview
  28. 7.5.3 Viatris Fexofenadine Hydrochloride Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Viatris Fexofenadine Hydrochloride Tablets Product Portfolio
  30. 7.5.5 Viatris Recent Developments
  31. 7.6 Teva Pharmaceuticals
  32. 7.6.1 Teva Pharmaceuticals Company Information
  33. 7.6.2 Teva Pharmaceuticals Business Overview
  34. 7.6.3 Teva Pharmaceuticals Fexofenadine Hydrochloride Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Teva Pharmaceuticals Fexofenadine Hydrochloride Tablets Product Portfolio
  36. 7.6.5 Teva Pharmaceuticals Recent Developments
  37. 7.7 Sun Pharmaceutical Industries Ltd.
  38. 7.7.1 Sun Pharmaceutical Industries Ltd. Company Information
  39. 7.7.2 Sun Pharmaceutical Industries Ltd. Business Overview
  40. 7.7.3 Sun Pharmaceutical Industries Ltd. Fexofenadine Hydrochloride Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Sun Pharmaceutical Industries Ltd. Fexofenadine Hydrochloride Tablets Product Portfolio
  42. 7.7.5 Sun Pharmaceutical Industries Ltd. Recent Developments
  43. 7.8 Sun Pharmaceutical Industries
  44. 7.8.1 Sun Pharmaceutical Industries Company Information
  45. 7.8.2 Sun Pharmaceutical Industries Business Overview
  46. 7.8.3 Sun Pharmaceutical Industries Fexofenadine Hydrochloride Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Sun Pharmaceutical Industries Fexofenadine Hydrochloride Tablets Product Portfolio
  48. 7.8.5 Sun Pharmaceutical Industries Recent Developments
  49. 7.9 Dr. Reddy's Laboratories
  50. 7.9.1 Dr. Reddy's Laboratories Company Information
  51. 7.9.2 Dr. Reddy's Laboratories Business Overview
  52. 7.9.3 Dr. Reddy's Laboratories Fexofenadine Hydrochloride Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Dr. Reddy's Laboratories Fexofenadine Hydrochloride Tablets Product Portfolio
  54. 7.9.5 Dr. Reddy's Laboratories Recent Developments
  55. 7.10 CSPC Pharmaceutical Group
  56. 7.10.1 CSPC Pharmaceutical Group Company Information
  57. 7.10.2 CSPC Pharmaceutical Group Business Overview
  58. 7.10.3 CSPC Pharmaceutical Group Fexofenadine Hydrochloride Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 CSPC Pharmaceutical Group Fexofenadine Hydrochloride Tablets Product Portfolio
  60. 7.10.5 CSPC Pharmaceutical Group Recent Developments
8 North America
  1. 8.1 North America Fexofenadine Hydrochloride Tablets Market Size by Type
  2. 8.1.1 North America Fexofenadine Hydrochloride Tablets Revenue by Type (2021-2032)
  3. 8.1.2 North America Fexofenadine Hydrochloride Tablets Sales by Type (2021-2032)
  4. 8.1.3 North America Fexofenadine Hydrochloride Tablets Price by Type (2021-2032)
  5. 8.2 North America Fexofenadine Hydrochloride Tablets Market Size by Application
  6. 8.2.1 North America Fexofenadine Hydrochloride Tablets Revenue by Application (2021-2032)
  7. 8.2.2 North America Fexofenadine Hydrochloride Tablets Sales by Application (2021-2032)
  8. 8.2.3 North America Fexofenadine Hydrochloride Tablets Price by Application (2021-2032)
  9. 8.3 North America Fexofenadine Hydrochloride Tablets Market Size by Country
  10. 8.3.1 North America Fexofenadine Hydrochloride Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Fexofenadine Hydrochloride Tablets Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Fexofenadine Hydrochloride Tablets Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Fexofenadine Hydrochloride Tablets Market Size by Type
  2. 9.1.1 Europe Fexofenadine Hydrochloride Tablets Revenue by Type (2021-2032)
  3. 9.1.2 Europe Fexofenadine Hydrochloride Tablets Sales by Type (2021-2032)
  4. 9.1.3 Europe Fexofenadine Hydrochloride Tablets Price by Type (2021-2032)
  5. 9.2 Europe Fexofenadine Hydrochloride Tablets Market Size by Application
  6. 9.2.1 Europe Fexofenadine Hydrochloride Tablets Revenue by Application (2021-2032)
  7. 9.2.2 Europe Fexofenadine Hydrochloride Tablets Sales by Application (2021-2032)
  8. 9.2.3 Europe Fexofenadine Hydrochloride Tablets Price by Application (2021-2032)
  9. 9.3 Europe Fexofenadine Hydrochloride Tablets Market Size by Country
  10. 9.3.1 Europe Fexofenadine Hydrochloride Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Fexofenadine Hydrochloride Tablets Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Fexofenadine Hydrochloride Tablets Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Fexofenadine Hydrochloride Tablets Market Size by Type
  2. 10.1.1 China Fexofenadine Hydrochloride Tablets Revenue by Type (2021-2032)
  3. 10.1.2 China Fexofenadine Hydrochloride Tablets Sales by Type (2021-2032)
  4. 10.1.3 China Fexofenadine Hydrochloride Tablets Price by Type (2021-2032)
  5. 10.2 China Fexofenadine Hydrochloride Tablets Market Size by Application
  6. 10.2.1 China Fexofenadine Hydrochloride Tablets Revenue by Application (2021-2032)
  7. 10.2.2 China Fexofenadine Hydrochloride Tablets Sales by Application (2021-2032)
  8. 10.2.3 China Fexofenadine Hydrochloride Tablets Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Fexofenadine Hydrochloride Tablets Market Size by Type
  2. 11.1.1 Asia Fexofenadine Hydrochloride Tablets Revenue by Type (2021-2032)
  3. 11.1.2 Asia Fexofenadine Hydrochloride Tablets Sales by Type (2021-2032)
  4. 11.1.3 Asia Fexofenadine Hydrochloride Tablets Price by Type (2021-2032)
  5. 11.2 Asia Fexofenadine Hydrochloride Tablets Market Size by Application
  6. 11.2.1 Asia Fexofenadine Hydrochloride Tablets Revenue by Application (2021-2032)
  7. 11.2.2 Asia Fexofenadine Hydrochloride Tablets Sales by Application (2021-2032)
  8. 11.2.3 Asia Fexofenadine Hydrochloride Tablets Price by Application (2021-2032)
  9. 11.3 Asia Fexofenadine Hydrochloride Tablets Market Size by Country
  10. 11.3.1 Asia Fexofenadine Hydrochloride Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Fexofenadine Hydrochloride Tablets Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Fexofenadine Hydrochloride Tablets Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Fexofenadine Hydrochloride Tablets Market Size by Type
  2. 12.1.1 SAMEA Fexofenadine Hydrochloride Tablets Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Fexofenadine Hydrochloride Tablets Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Fexofenadine Hydrochloride Tablets Price by Type (2021-2032)
  5. 12.2 SAMEA Fexofenadine Hydrochloride Tablets Market Size by Application
  6. 12.2.1 SAMEA Fexofenadine Hydrochloride Tablets Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Fexofenadine Hydrochloride Tablets Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Fexofenadine Hydrochloride Tablets Price by Application (2021-2032)
  9. 12.3 SAMEA Fexofenadine Hydrochloride Tablets Market Size by Country
  10. 12.3.1 SAMEA Fexofenadine Hydrochloride Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Fexofenadine Hydrochloride Tablets Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Fexofenadine Hydrochloride Tablets Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Fexofenadine Hydrochloride Tablets Value Chain Analysis
  2. 13.1.1 Fexofenadine Hydrochloride Tablets Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Fexofenadine Hydrochloride Tablets Production Mode & Process
  6. 13.2 Fexofenadine Hydrochloride Tablets Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Fexofenadine Hydrochloride Tablets Distributors
  9. 13.2.3 Fexofenadine Hydrochloride Tablets Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst